Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | DT204 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
DT204 is a SCF/SKP2 inhibitor that targets the ubiquitin/proteasome system, specifically inhibiting SKP1, CUL1, and COMMD1, which may result in restored sensitivity to proteasome inhibitors or overcome proteasome inhibitor resistance (PMID: 27677741). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bortezomib + DT204 | Bortezomib DT204 | 0 | 0 |
| Carfilzomib + DT204 | Carfilzomib DT204 | 0 | 0 |
| DT204 | DT204 | 0 | 0 |
| DT204 + Ixazomib | DT204 Ixazomib | 0 | 0 |